Free Trial

Arteris (AIP) Expected to Announce Earnings on Tuesday

Arteris logo with Computer and Technology background

Arteris (NASDAQ:AIP - Get Free Report) is expected to be releasing its Q1 2025 earnings data after the market closes on Tuesday, May 13th. Analysts expect Arteris to post earnings of ($0.11) per share and revenue of $15.90 million for the quarter. Arteris has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The business had revenue of $15.49 million during the quarter, compared to analysts' expectations of $15.34 million. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Arteris Price Performance

Shares of AIP traded up $0.02 during mid-day trading on Tuesday, reaching $6.73. 14,228 shares of the company's stock were exchanged, compared to its average volume of 201,220. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. The company has a market cap of $275.38 million, a price-to-earnings ratio of -7.71 and a beta of 1.31. Arteris has a 52-week low of $5.46 and a 52-week high of $12.64. The company has a 50-day simple moving average of $7.28 and a two-hundred day simple moving average of $8.63.

Insider Activity

In other Arteris news, CFO Nicholas B. Hawkins sold 4,949 shares of the company's stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $6.03, for a total transaction of $29,842.47. Following the transaction, the chief financial officer now directly owns 176,596 shares in the company, valued at approximately $1,064,873.88. This represents a 2.73 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Laurent R. Moll sold 4,703 shares of the business's stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total value of $33,485.36. Following the completion of the transaction, the chief operating officer now directly owns 482,833 shares of the company's stock, valued at approximately $3,437,770.96. The trade was a 0.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 100,927 shares of company stock valued at $918,829 over the last 90 days. 33.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Northland Securities raised their price objective on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Wednesday, February 19th. Rosenblatt Securities restated a "buy" rating and set a $15.00 price objective on shares of Arteris in a research note on Tuesday, February 18th.

Check Out Our Latest Stock Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Earnings History for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines